Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-31

FDA Approved: BUPRENORPHINE — Supplemental Application (INGENUS PHARMACEUTICALS, LLC)

View source ↗

Summary

The FDA approved a supplemental application for buprenorphine from Ingenus Pharmaceuticals, granting approval of a generic buprenorphine product under ANDA21027…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

SUPPL AP for BUPRENORPHINE (BUPRENORPHINE)